Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample

• Eric J. Peters,

  Current address: Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina School of Pharmacy, Chapel Hill, North Carolina, United States of America

  Affiliation Department of Psychiatry and Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Susan L. Slager,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Jeffrey B. Kraft,

  Affiliation Department of Psychiatry and Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Greg D. Jenkins,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Megan S. Reinalda,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Patrick J. McGrath,

  Affiliation Department of Psychiatry, Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute, New York, New York, United States of America

  ⨯
• Steven P. Hamilton

  *To whom correspondence should be addressed. E-mail: SteveH@lppi.ucsf.edu

  Affiliation Department of Psychiatry and Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America

  ⨯